Haemonetics (NYSE: HAE) announced today that it acquired percutaneous vessel closure device maker Vivasure Medical. Galway, Ireland-based Vivasure develops the PerQSeal Elite system, the first sutureless, fully absorbable synthetic implant for large-bore vessel punctures. Placement occurs from inside the vessel. It makes deployment simpler and … [Read more...] about Haemonetics acquires Irish vessel closure company Vivasure for $116.4M
